Article
Genetic basis for differences in debrisoquin polymorphism between a Spanish and other white populations.
Clinical pharmacology and therapeutics - 1 Apr 1994
Agúndez J A, Martínez C, Ledesma M C, Ladona M G, Ladero J M, Benítez J
Abstract excerpt
The debrisoquin hydroxylation polymorphism is an autosomic recessive trait of the cytochrome P450IID6, an enzyme involved in drug metabolism, that affects 5% to 10% of white subjects. The genetic basis of this polymorphism was studied in 258 unrelated Spanish white subjects. The results revealed that about 5% of the subjects were homozygous for mutant alleles and that about 1% of the subjects carried alleles that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.